Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong · Delayed Price · Currency is HKD 35.10
-0.84 (-2.34%)
Sep 19, 2025, 9:45 AM HKT
HKG:3692 Market Cap
HKG:3692 has a market cap or net worth of 217.57 billion as of September 18, 2025. Its market cap has increased by 101.61% in one year.
Market Cap
217.57B
Enterprise Value
187.98B
Revenue
14.45B
Ranking
n/a
PE Ratio
40.85
Stock Price
35.10
Market Cap Chart
Since June 14, 2019, HKG:3692's market cap has increased from 111.27B to 217.57B, an increase of 95.55%. That is a compound annual growth rate of 11.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 217.57B | 112.17% |
| Dec 31, 2024 | 102.55B | 9.84% |
| Dec 29, 2023 | 93.36B | 6.25% |
| Dec 30, 2022 | 87.86B | -21.92% |
| Dec 31, 2021 | 112.52B | -49.44% |
| Dec 31, 2020 | 222.55B | 48.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 284.54B |
| JD Health International | 209.86B |
| Innovent Biologics | 163.74B |
| WuXi Biologics | 157.51B |
| Sino Biopharmaceutical | 155.95B |
| CSPC Pharmaceutical Group | 120.50B |
| Akeso | 120.39B |
| Sichuan Kelun-Biotech Biopharmaceutical | 116.33B |